Category: news

Same Great Service…New Address!

Same Great Service…New Address!
open

We are proud to announce Front Range Laboratories has a new home. Effective today, we are operational in a much larger, customized facility only three miles away from our former lab. Our reason for moving is that we had simply outgrown our space. The new facility has significantly more square footage, which allows us to continue to serve you at the level you expect, and gives us room to grow. Fortunately, the proximity of the former and current labs has enabled us to make a smooth transition by giving us the ability to provide services (where possible) at both labs. This is why you have not seen and will not see any interruption in your services due to our move.

We are excited that this new facility will allow us to further our ability to respond to YOUR business demands. We have space to increase our science personnel as needed. And we will be able to add even more state-of-the-art technology over time, allowing us to continue to help you navigate the heightened compliance demands in the compounding industry.

The bottom line is that we are growing and it is because of you. We would like to thank you for making this move necessary by entrusting us with your business. Should you have any questions or concerns about the move, or anything at all, please do not hesitate to contact me. Front Range Laboratories looks forward to continuing to be your science partner in patient care.

Sincerely,

Michael Travis
President, Front Range Laboratories
970-593-0171
michaeltravis@frontrangelabs.com
***

Please Update Your Records And Shipping Info
rolodex green

Our New Address

3985 S. Lincoln Avenue
Loveland, CO 80537

Same Phone
970-593-0171, 1-888-PHARM QC

Same Fax
970-593-9044

We ARE Growing!
dddxyz_design_woodstock_office_featured

Did you know?

In the last year, Front Range Laboratories has:

▪ Invested nearly a million dollars in new state-of-the-art equipment
▪ Tripled its staff
▪ Hired not only more chemists and microbiologists, but also increased personnel across all departments including client services and quality

10/04/2012 – Front Range Laboratories Response: Meningitis Outbreak

10/04/2012 – Front Range Laboratories Response: Meningitis Outbreak

As you are most likely aware, a recent outbreak of a rare type of meningitis has been linked to spinal injections for back pain and has killed four people and sickened at least 30 others in five states including Tennessee, Florida, North Carolina, Virginia and Maryland.

Recent reports cite that this outbreak has been linked to a Methylprednisolone Acetate PF injectable product dispensed from a compounding pharmacy. The compounding pharmacy implicated in news reports is NOT a client of Front Range Laboratories.

Over the coming weeks, it is likely that our entire industry will face intense scrutiny in regards to how we conduct testing to ensure patient safety and prevent outbreaks like this one. In fact, we have already received many calls from you, our clients, inquiring if the testing we perform on your products would detect this type of contamination. The answer is YES.

Front Range Laboratories is diligent in our strict adherence to USP testing standards. As you may know, USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are developed and relied upon in more than 140 countries (www.usp.org).

The sterility testing we carry out on a daily basis is according to USP71. This method requires validation of the drug substance against four different types of control organisms that represent a broad spectrum of microbiological species. They are Gram Positive, Gram Negative, yeast and mold samples. To evaluate your product we must be able to show the recovery of each control against the drug product.

The mold control recommended by USP is Aspergillus. Regarding the current situation, this is reportedly the genus of microbe that is at fault in the suspected contaminated drug. Many have asked if a separate fungal test is required to detect this type of microbe. The answer is NO; you do not have to run a specific fungal test on your product.

Your products are tested within a class 6 cleanroom environment by a microbiologist and a certified aseptic compounding pharmacy technician. Samples are processed the same day they arrive into our facility.

When talking to your clients, you can inform them that the sterility testing carried out by your laboratory:
* Is in accordance with USP71
* Utilizes two incubational temperatures
* Uses two different incubational temperatures for the evaluation
* Screens for Gram Negative Bacteria, Gram Positive Bacteria, Yeast and Mold

For more detail, you can find the USP71 recommended sampling plan atwww.FrontRangeLabs.com

Additionally, USP currently provides the option for laboratories to employ newer technologies for sterility testing that are referred to as Rapid Microbial Methods (RMM). We have invested in two of these technologies: Flow-Cytometry and Bioluminescence. These methods provide a benefit to our clients that are two-fold. First, by using an automated system for the detection we no longer rely solely on human visual observation to judge the pass/fail basis of the end-product. Second, with the increased sensitivity of our detection with both systems, we are able to move incubational times down from 14 days to 3-5 days, depending on the product. This gives us the ability to notify clients in an expedited manor if contamination is detected in their products.Validation of your individual products can be performed so you have documentation to show your clients that your testing method does cover your product. If you have not yet switched your products over to our Rapid Microbial Methods and are interested, please give us a call today so we can assist you with this advanced testing technology.

Our goal is to provide you with end-product testing that is in compliance with USP guidelines within a cGMP compliant environment. We view ourselves as your partner in delivering end-products of the highest quality possible to your clients and the individual patients who receive these medications. We continue to provide advanced training to our employees, as well as re-investing in our laboratory to provide the best possible technology available to evaluate your end-products.

I hope that this information will address any concerns you may have at this time about the testing services we provide. Should you require additional documentation to reassure your clients that your products have been tested properly or have any questions, please do not hesitate to contact me at 1.888.pHarmQC (1.888.742.7672).

Sincerely,
Michael Travis
President, Front Range Laboratories

Data from the Lab

Happy New Fiscal Year!

As we close the books on 2011, and turn the page on a New Year at Front Range Laboratories, we wanted to take a moment to thank you for your business. We have many loyal customers, you among them, whom we are honored to work with each and every day. We take great pride in the relationships we have built over the past 15 years, and as we move into 2012, we look forward to strengthening those relationships, continually working as your trusted sciencepartner.

Toward that end, we would like to share some noteworthy developments at Front Range Laboratories from the past year. We are excited because these are investments not only in our future, but in our ability to serve you better. Rest assured that as we continue to grow, we are still dedicated to providing you with the same knowledgeable and personal support. And once again, thank you for choosing Front Range Laboratories for your testing needs.
ribbon cuttingOur move to a new neighborhood attracted the notice of Loveland’s mayor, Cecil A. Gutierrez (pictured far right), who visited our open house to learn more about our business.

We Moved!

We expanded our service offering and doubled our personnel with the lease of a 4,500 sq ft facility in downtown Loveland, Colorado. The addition of state-of-the-art equipment, expanded service offerings and technical staff necessitated our move to this more efficient facility. Our new space is a perfect fit for our growing business; we are able to offer a wider range of testing services and our Northern Colorado location continues to be a draw for employees and customers alike.
19858479_35qj.png

We Joined The Compounders Group

We seized the opportunity to increase our support to the industry by becoming a vendor member of The Compounders Group (TCG), a group dedicated to serving the business of compounding pharmacists. This means that compounding pharmacists who are TCG members and Front Range Laboratories customers will be eligible for benefits pre-negotiated through TCG. If you are a member of TCG, and would like to learn more about these benefits, please don’t hesitate to contact us. If you’re not a member, or haven’t heard of TCG yet, we encourage you to check out their website or call us for more information.
IMAG0192mpaesOur new MP-AES is ready for action! The entire staff has been trained to use this advanced machine.

We Got a New “Toy”

Last but not least, we made a serious investment in our instrumentation at the end of 2011. We are proud to announce that we house the first commercial installation in the US of an Agilent Microwave Plasma – Atomic Emission Spectroscopy (MP-AES). As you may know, it is used for heavy metal analysis, from baseline detection to active ingredient analysis. This is a completely new technology, a hybrid between older atomic absorption technology and higher-end inductively coupled plasma (ICP) analysis. Simply put, it enables cutting-edge testing. We consider this addition a testament to the depth and breadth of high-quality analysis that we can provide. We have other, similar investments in the works for 2012 and we will keep you apprised of them as they happen. In the meantime, please don’t hesitate to call me if you’d like to learn more about this new capability.
***

We hope that you share our excitement about these developments and our optimism for a successful New Year. I will be in touch throughout the year with similar updates. In the meantime, please don’t hesitate to contact me with any questions or comments.

Sincerely Yours,
Michael Travis
Owner and President, Front Range Laboratories, Inc.